These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11401502)

  • 1. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.
    Chiba H; Inokoshi J; Okamoto M; Asanuma S; Matsuzaki Ki ; Iwama M; Mizumoto K; Tanaka H; Oheda M; Fujita K; Nakashima H; Shinose M; Takahashi Y; Omura S
    Biochem Biophys Res Commun; 2001 Mar; 282(2):595-601. PubMed ID: 11401502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of actinohivin, a novel anti-HIV protein from an actinomycete, and its expression in Escherichia coli.
    Inokoshi J; Chiba H; Asanuma S; Takahashi A; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1261-5. PubMed ID: 11243871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential regions for antiviral activities of actinohivin, a sugar-binding anti-human immunodeficiency virus protein from an actinomycete.
    Takahashi A; Inokoshi J; Chiba H; Omura S; Tanaka H
    Arch Biochem Biophys; 2005 May; 437(2):233-40. PubMed ID: 15850563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
    Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity.
    Takahashi A; Inokoshi J; Hachiya A; Oka S; Omura S; Tanaka H
    J Antibiot (Tokyo); 2011 Aug; 64(8):551-7. PubMed ID: 21694730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum.
    Gustafson KR; Sowder RC; Henderson LE; Cardellina JH; McMahon JB; Rajamani U; Pannell LK; Boyd MR
    Biochem Biophys Res Commun; 1997 Sep; 238(1):223-8. PubMed ID: 9299483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.
    Bokesch HR; O'Keefe BR; McKee TC; Pannell LK; Patterson GM; Gardella RS; Sowder RC; Turpin J; Watson K; Buckheit RW; Boyd MR
    Biochemistry; 2003 Mar; 42(9):2578-84. PubMed ID: 12614152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel heme-containing protein with anti-HIV-1 activity from skin secretions of Bufo andrewsi.
    Zhao Y; Jin Y; Wang JH; Wang RR; Yang LM; Lee WH; Zheng YT; Zhang Y
    Toxicon; 2005 Nov; 46(6):619-24. PubMed ID: 16157359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression.
    Ui H; Asanuma S; Chiba H; Takahashi A; Yamaguchi Y; Masuma R; Omura S; Tanaka H
    J Antibiot (Tokyo); 2005 Aug; 58(8):514-8. PubMed ID: 16266123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple screening system for anti-HIV drugs: syncytium formation assay using T-cell line tropic and macrophage tropic HIV env expressing cell lines--establishment and validation.
    Chiba H; Asanuma S; Okamoto M; Inokoshi J; Tanaka H; Fujita K; Omura S
    J Antibiot (Tokyo); 2001 Oct; 54(10):818-26. PubMed ID: 11776437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actinohivin: specific amino acid residues essential for anti-HIV activity.
    Takahashi A; Inokoshi J; Tsunoda M; Suzuki K; Takenaka A; Sekiguchi T; Omura S; Tanaka H
    J Antibiot (Tokyo); 2010 Nov; 63(11):661-5. PubMed ID: 20842142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro.
    Pang W; Wang RR; Yang LM; Liu CM; Tien P; Zheng YT
    Virology; 2008 Jul; 377(1):80-7. PubMed ID: 18499209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syncytium forming capacity of HIV 1 strains in inhibited by pretreatment of CD4 expressing cells with 3'-azido-3'-deoxythymidine but not by alpha interferon.
    Ruţă SM; Cernescu C
    Rev Roum Virol; 1994; 45(3-4):171-83. PubMed ID: 7619738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of anti-HIV peptides from Dorstenia contrajerva and Treculia obovoidea.
    Bokesch HR; Charan RD; Meragelman KM; Beutler JA; Gardella R; O'Keefe BR; McKee TC; McMahon JB
    FEBS Lett; 2004 Jun; 567(2-3):287-90. PubMed ID: 15178338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
    Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
    Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
    Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
    J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
    Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1.
    McDonald RA; Chang G; Michael NL
    J Hum Virol; 2001; 4(4):179-87. PubMed ID: 11694845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.